Sixty-eight family physicians in Toronto were personally interviewed and reported the drugs they prescribed for a list of functional ailments, estimated extent of their per-patient prescribing of psychoactive drugs, also their attitudes toward emotionally disturbed or neurotic patients. Numerous variables were explored, but the only important correlation with lower prescribing rates was the period of graduation (1955 or later), irrespective of the patient population composition. Attitudes toward neurotics had no connection with per-patient prescribing, older graduates holding as favorable attitudes as more recent ones. An unfavorable attitude did, however, correlate with a greater number of patients seen on an average day. Background characteristics, professional associations and types of practices are described. Some irrational elements in prescribing are discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2370576PMC

Publication Analysis

Top Keywords

psychoactive drugs
8
per-patient prescribing
8
family practitioners
4
practitioners prescription
4
prescription psychoactive
4
drugs sixty-eight
4
sixty-eight family
4
family physicians
4
physicians toronto
4
toronto personally
4

Similar Publications

Exposure to Secondhand Cannabis Smoke Among Children.

JAMA Netw Open

January 2025

Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego.

Importance: The degree that in-home cannabis smoking can be detected in the urine of resident children is unclear.

Objective: Test association of in-home cannabis smoking with urinary cannabinoids in children living at home.

Design, Setting, And Participants: This cross-sectional study used baseline data from Project Fresh Air, a 2012-2016 randomized clinical trial to reduce fine particulate matter levels.

View Article and Find Full Text PDF

Background: Muscarinic receptor agonism and positive allosteric modulation is a promising mechanism of action for treating psychosis, not present in most D2R-blocking antipsychotics. Xanomeline, an M1/M4-preferring agonist, has shown efficacy in late-stage clinical trials, with more compounds being investigated. Therefore, we aim to synthesize evidence on the preclinical efficacy of muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis to provide unique insights and evidence-based information to guide drug development.

View Article and Find Full Text PDF

To evade legal controls, new psychoactive substances (NPS), which have been designed as substitutes for traditional and synthetic drugs, are gradually dominating the drug market. Synthetic cannabinoids (SCs), which account for the majority of NPS, are rapidly being derivatized; consequently, controlling increasing abuse by merely listing individual compounds is difficult. Therefore, China has included the entire SC category of SCs listed as legal controlled substances since July 1, 2021.

View Article and Find Full Text PDF

This study aimed to characterize the triple-hit schizophrenia-like model rats (Wisket) by the assessment of (1) behavioral parameters in different test conditions (reward-based Ambitus test and HomeManner system) for a prolonged period, (2) cerebral muscarinic M1 receptor (M1R) expression, and (3) the effects of olanzapine treatment on these parameters. Wistar (control) and Wisket rats were injected for three consecutive weeks with olanzapine depot (100 mg/kg) and spent 4 weeks in large cages with environmental enrichment (HomeManner). The vehicle-treated Wisket rats spent longer time awake with decreased grooming activity compared to controls, without changes in their active social behavior (sniffing, playing, fighting) obtained in HomeManner.

View Article and Find Full Text PDF

Effect of combination therapy of methylfolate with antidepressants in patients with depressive disorder.

BMC Pharmacol Toxicol

January 2025

Department of Community Medicine, Islamic International Medical College (IIMC), Riphah International University, Rawalpindi, Pakistan.

Objective: To determine the relative effectiveness of combination therapy of antidepressants with low-dose methylfolate versus antidepressant monotherapy in patients with depressive disorder.

Methods: In an open-label clinical trial, forty-four patients with depressive disorder (6A70, 6A71, and 6A72 according to ICD-11) received an evidence-based antidepressant therapy (either escitalopram 10-20 mg, sertraline 50-100 mg, fluoxetine 20-40 mg, duloxetine 30-60 mg, mirtazapine 15-30 mg, venlafaxine 75-150 mg, trazodone 50-100 mg, amitriptyline 25-75 mg, or clomipramine 25-75 mg orally daily for 4 weeks). The experimental group, Group B was additionally given a dose of methylfolate 800 µg daily for four weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!